The prevalence of hypertension was significantly increased with duration of highly active antiretroviral therapy (HAART) in HIV-infected Cameroonians.
CamerounVIH/sidapublié 2013Diabetes & metabolismeurope_pmcdocument de 12 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
1 754 evidences · page 69 / 71
The prevalence of hypertension was significantly increased with duration of highly active antiretroviral therapy (HAART) in HIV-infected Cameroonians.
CamerounVIH/sidapublié 2013Diabetes & metabolismeurope_pmcdocument de 12 observations
-70,72 beta_coefficientIn age, sex and body mass index adjusted models, increasing Log10LTL was associated with decreasing HOMA-β (β = -70.72).
Camerouncardio-metabolic diseasespublié 2022Medicineeurope_pmcdocument de 12 observations
1 841 patientsA total of 1841 patients with diabetes were admitted to the Yaounde Central Hospital, Cameroon, between 2000 and 2007.
Cameroundiabète (non précisé)observé 2000 through 2007publié 2009The international journal of lower extremity woundseurope_pmcdocument de 3 observationsDOI 10.1177/1534734609349704
8,2 %In 2019, 8.2% of all adolescent deaths were due to self-harm.
Camerounself-harmobservé 2019publié 2021Lancet (London, England)europe_pmcdocument de 13 observations
97,6 %Concordance between RH phenotype prediction and serologic testing was 97.6% for the five major RH antigens.
CameroundrépanocytoseHAL · Unilimdocument de 45 observations
31,7 %The highest estimated lifetime risk of stroke according to GBD region was in Central Europe at 31.7%.
CamerounAVCobservé 2016publié 2018The New England journal of medicineeurope_pmcdocument de 12 observations
In a clinical trial, capsaicin showed no significant difference in median pain intensity compared to placebo at eight weeks: 6.6 [6.0–7.0] vs 5.2 [5.0–6.0] (p=0.54).
Camerounpainful diabetic neuropathypublié 2020Cureuseurope_pmcdocument de 5 observationsDOI 10.7759/cureus.11147
0,88 %In Monatélé Health Area, the prevalence of epilepsy recorded by CDDs was 0.88%.
CamerounépilepsieHAL · Unilimdocument de 53 observations
95 %Specificity for the detection of macular edema using the smartphone-based retinal camera was 95%.
Camerounmacular edemapublié 2019Ophthalmic surgery, lasers & imaging retinaeurope_pmcdocument de 16 observations
-0,35 rsAdiponectin correlated negatively with insulin resistance (rs = -0.35; p = 0.01).
Camerouninsulin resistancepublié 2007Cardiovascular diabetologyeurope_pmcdocument de 4 observations
40,9 %Among patients with NRTI resistance, 18/44 (40.9%) carried Thymidine Analog Mutations (TAMs).
CamerounVIH/sidapublié 2013Journal of the International AIDS SocietyOpenAlexdocument de 3 observationsDOI 10.7448/ias.16.1.18004
24,1 %Global age-standardised prevalence of raised blood pressure was 24.1% in men and 20.1% in women in 2015.
Camerounraised blood pressureobservé 2015publié 2017Lancet (London, England)europe_pmcdocument de 7 observations
26,92 %Among 26 participants with COVID-19 IgM+/IgG−, 26.92% had negative PCR and 73.08% had positive PCR.
CamerounCOVID-19observé November 2020 to July 2021publié 2023VirusesOpenAlexdocument de 12 observationsDOI 10.3390/v15020407
129 infective_bite_per_person_per_yearAnnual malaria transmission was estimated at 129 infective bite/person/year in the Mfou district.
CamerounpaludismeHAL · Unilimdocument de 106 observations
2,05 RRAmong 10,615 individuals in sub-Saharan Africa, anti-retroviral therapy was associated with a two-fold higher probability of raised triglycerides (>2.3 mmol/L), with a relative risk of 2.05.
CamerounVIH/sidaobservé 2003–2014publié 2018Global health, epidemiology and genomicseurope_pmcdocument de 2 observations
46,7 %Depressive symptoms (PHQ-9 score ≥5) were reported in 46.7% of patients with type 2 diabetes treated with insulin only.
Cameroundepressive symptoms · diabète de type 2observé 2011publié 2021Diabetes careeurope_pmcdocument de 4 observations
The prevalence of dyspnea and congestive heart failure was low and did not differ significantly between sickle cell disease patients and healthy controls in Cameroon, Mali, and Senegal.
Cameroun · Mali · Sénégaldrépanocytosepublié 2018Frontiers in MedicineOpenAlexdocument de 10 observationsDOI 10.3389/fmed.2018.00323
21 percent_of_GNI_per_capitaThe minimum estimated cost for the treatment of uncomplicated diabetes in the public sector amounts to 21%–34% of the country's gross national income per capita.
Camerountype-2 diabetespublié 2015World journal of diabeteseurope_pmcdocument de 3 observations
5,3 %Among 76 patients followed-up at endpoint, 5.3% (4/76) harbored HIV drug resistance.
CamerounVIH/sidaobservé 2009-2011publié 2013PLoS ONEOpenAlexdocument de 8 observationsDOI 10.1371/journal.pone.0072680
30 %The age-standardized proportion of diabetes that was previously undiagnosed and detected in survey screening ranged from 30% in the high-income western region to 66% in south Asia.
Cameroundiabète (non précisé)publié 2023Nature medicineeurope_pmc
15,1 %HHV-8 antibodies were found in 16 patients (15.1%) with nonketotic DM-2.
Camerounnonketotic type 2 diabetes mellituspublié 2008JAMAeurope_pmcdocument de 4 observationsDOI 10.1001/jama.299.23.2770
594 000 000 inhabitantsThe number of adults with raised blood pressure increased from 594 million in 1975 to 1.13 billion in 2015.
Camerounraised blood pressureobservé 1975publié 2017Lancet (London, England)europe_pmcdocument de 7 observations
0,8 %The age-standardized prevalence of diabetes in the urban population of Cameroon was 0.8% for men.
Cameroundiabète (non précisé)publié 1997Diabetologiaeurope_pmcdocument de 12 observationsDOI 10.1007/s001250050755
23 %Among 110 HIV-1-infected, drug-naïve Cameroonians, 25 (23%) had unclassifiable protease (PR) sequences.
CamerounVIH/sidapublié 2002Journal of Clinical MicrobiologyOpenAlexdocument de 12 observations
0,736 AUCThe area under the receiver operating characteristics curve (AUC) for hypertension prediction ranged from 0.736 to 0.739 with combinations of anthropometric measures of adiposity.
Camerounhypertension artérielleobservé 2017publié 2021Health science reportseurope_pmcdocument de 5 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.